Rapport Therapeutics

RAPP

Rapport Therapeutics has been a target of short sellers for a while. The current short interest of 4.66% is roughly at the average of the last 12 months (5.61%).

Short Interest Trend

Share Price

Total NSP

4.66%

+0.02%

vs. last month

Also interesting? All insider buys at Rapport Therapeutics

Found an error? Questions? Ideas?